UCB’s developmental treatment may be eligible for patient access
Category: News
Demonstrate your skill and prowess by entering this year’s awards!
New initiative aims to accelerate diagnosis and ease NHS pressures
Company seeks approval for new schedules to improve patient convenience
Application seeks reduced infusion frequency to support patient flexibility
Approval marks milestone for AI use in frontline care
New therapy offers hope for patients with limited option
Study paves the way for personalised therapies for osteoarthritis sufferer
CHMP recommendation brings new hope for patients
VYVGART could be the first CIDP drug with a novel mechanism in 30 years